Resource data sheet
DNA Bank Top
Please review the QC test results indicated by check icon below as well as clone information before placing your order.

pGL4-phSLC2A1 (#RDB07814)

Promoter collection, Human SLCA1 promoter

Alternative name U3288-2
Clone info. PCR amplified human SLCA1 promoter sequence was inserted into a firefly luciferase vector. Genomic DNA (42,960,401 - 42,959,101nt of NC_000001.11) corresponding to 1 to 76nt of NM_006516.2 and 1.2 kb up-stream was cloned.
Comment PCR cloning, forward primer: ttgatcagacctttgga; reverse primer: ggcattcgctgtgtga.
Vector backbone pGL4.10 [Luc2] (Plasmid)
Selectable markers Amp^r
Gene/insert name Human solute carrier family 2 (facilitated glucose transporter), member 1 genomic DNA
Depositor|Developer DNA Bank, |
 

Distribution information

Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms
Order form [Credit Card Payment] [Bank Transfer Payment] [Example of order form ]
MTA, for use for not-for-profit academic purpose [Word] [Example of MTA ]
Please visit Information of Request for Distribution.[link] 
Terms and conditions for distribution In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested.
Additional terms and conditions:
The use of the BIOLOGICAL RESOURCE is restricted to the academic researches conducted by non-profit organization. By using this material, the RECIPIENT agrees to be bound by the conditions of the limited use statement of the Promega Corporation.
提供案内 (日本国内) [open/close]

必要書類
提供依頼書  [依頼書の記入例 ]
提供同意書 (MTA, 非営利学術目的用)[Word] [MTAの記入例 ]
手続きの概要は、「提供申込みについて[link]」をご覧ください。
MTAに書く使用条件 謝辞の表明を必要とする。
MTAに書く付加的使用条件:
本件リソースの使用は学術機関での学術研究に限る。本件リソースの使用にあたって、利用者はプロメガ社の限定使用条件に従う必要がある。

Catalog # Resource name Shipping form Fee (non-profit org.)
RDB07814 pGL4-phSLC2A1 DNA solution JPY 9,460 (not-for-profit academic purpose)
plus cost of shipping containers, dry ice (if required) and shipping charge

Please review the QC test results indicated by check icon below as well as clone information before placing your order.

How to cite this biological resource

Materials & Methods section:

The pGL4-phSLC2A1 was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB07814).

Reference section:

Further references such as user reports and related articles (go to bottom)


QC test results

RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by check icon as well as clone information before placing your order.

Test sheet RDB07814_A5Dnp1-2.pdf check

Nucleotide sequence of a portion of this resource (if available).

Primer: pGL4ins_F (Pr0665)
Region: pause site, insert 5'
Sequence file: RDB07814_A5Dna.seq check
>07814_07814_B0J1F_pGL4ins_F_A12_03_ABI24.ab1
    1 NNNNNNNNNN NNNNNNNNNC NNNNNNNNNN NNNGCTNNNC CCNGTGCAAG TGCAGGTGCC
   61 AGAACATTTC TCTGGCCTAA CTGGCCGGTA CCTGAGCTCG CTAGCCTCGA GGATTTGATC
  121 AGACCTTTGG ACTGGGGGTC CTTCCCTTCA CTGTGTCTCA AGTAAGGCAC TGGTCTAGAG
  181 GAAATAAGGT GAAGTCAGAT GATAGCAATA CCACTACCAG TGCAGTGGCA CATGCCTGCA
  241 CTCCCAGCTA CTACGGAGGC TAAGGTGGGA GGATCACTTG AGCCCAGGAG TTTGAGACCA
  301 GCATTTATTT ATTTACTAAC AGACTAAATA AATAAACCAA CAATACCACC AACCAGTAAA
  361 TGAGAACTTC CATGCTAAAC ACTTCATGAG CTTATCTGGA AATTGCACCT CTCCTGATAG
  421 CAATGAGATT GGTGTGGGAA TTCCATTTAC TCATAAGAAG ACAGCCTCGG CCGGGCTCAG
  481 TGGCTCACGC CTGTAATCCC AGTACTTTGG GAGGCGAGGT GGGTGGATCA CGAGGTCAAG
  541 AGTTCAAGAC CAGCCTGGCC AAAATGGTGA AACCCCGTCT CTACTAAAAA TAAAAATAAT
  601 TAGCCAGGGG TGATAGCGGG CGCCTGTAAT CCCAGCTACT CGGGAGGCTG AGGCAGANAA
  661 CTGCTTGAAT CCGGGAGGCG GAGGTTACAG TGAGCCGAGA TCGTGCCGCT GCACTCCANC
  721 CTGGGCGACA GAGCGAGACT CTGTCTGANA AAAAAAAAAA TTNAANAAAA AAACGAAAAC
  781 NGCCTCNCTG GCNAGGAANC TCNCCCAGGN NCGCGGNCGG GCCAGTATAC AGTTGAGCTN
  841 GTTCNAANCC GNNGTCTATC ATGTCCTTNA TGTCCTATCA TGTCAGNNAG TTANCCTGNN
  901 TTTCNNATTT TCCNCACTTN NAGGNTCACC ATANANTCAC NNGAACTGTG AGAANTANAN
  961 GNANNNCGNN CNNNNNNAGG NGATTTNNAN NNCCNNNNNT TGANNNGGGN NTNNNNTTNN
1021 NNNGNNNNNN NNNN
//
Primer: pGL4ins_R (Pr0666)
Region: Luc 5', insert 3'
Sequence file: RDB07814_A5Dnb.seq check
>07814_07814_B0J1F_pGL4ins_R_B12_06_ABI24.ab1
    1 NNNNNNNNNN NNNNNNNNNN NNNNGNNNAG ANNGGNGCTG GGCCCTTCTT AATGTTTTTG
   61 GCATCTTCNA TGGTGGCTTT ACCAACAGTA CCGGATTGCC AAGCTTGGCC GCCGAGGCCA
  121 GATCTTGATG GCATTCGCTG TGTGACTCAG GGCAAGTGTG CGCACCTCTC TGAGCCTCCG
  181 CGGCCTTCTC TAGCAAAATG GTGGAGCCGG TACCCGGCTG TAAGGCAAGC TGGGATGCGC
  241 GGAGTAGCGG GTGGAAAGCT GGACTGGAGT TCTCACTCGG CCGCTGGGTG ACTTCGGTGC
  301 ACTAGGGATA GTAACAGTAC CACCTCGTAG GGTTGTAGAA AGACCAAGTG AGTTAATATT
  361 TGTAAAGTGT TTAGAACAGC GTCTACTGCA TGGAAAGTAG TATTTATTTG TTAGAGAGAC
  421 TCCAGGAGGT CTTGCCCAGG GATTGACTTC TCCCTTCCCT GTCTCCACCC CCCACATTCC
  481 CGTTTGTGAG CCAAGCCTTG CTTTTGCACC GGCCGGGCTC TCTTGCCTGG AAATGCATAC
  541 CCATCTCAAA CCTGGGCTTT AAAATCACCT CCTCTGGGAC GCCTTCCTCT ACTTCTCACA
  601 GTTCAGGTGA GTCTATGGTG ACCTGTAAGT GTGGAAAATA TGAAAGGCAG GCTAACTGAC
  661 TGACATGATA GGACATTAAG GACATGATAG ACCTCGGGTT TGAACCAGCT CAACTGTATA
  721 CTGGCCCGGC CGCGATCCTG GGCGAGTTCC TGGCCAGTGA GGCTGTTTTC GTTTTTTTCT
  781 TTAATTTTTT TTTTTCTCAG ACAGAGTCTC GCTCTGTCGC CCAGGCTGGA NNGCAGCGGC
  841 ACGATCTCGG CTCACTGTAA CCTCCGCCTC NCGGANNCAA GCAGTTCTCT GCCTCANCCT
  901 CCNGANNANC TGGGNANTAC NGGNGCCCGC TATCNCCCCN GGCNNNNTAT TTTTATTTTT
  961 TAGNANANAN NGGGGTTTCN NNNNTTTNGG NNNNGNCTNG NNNNNNNCTN NTNGANCNNN
1021 NNNNANNNNN CCNNCCNNCN NNNCNNNANN NNNNNNNN
//
Primer: pAxCALNLF1 (Pr0166)
Region: Luc 3',
Sequence file: RDB07814_A5Dnc.seq check
>07814_07814_B0J1F_pAxCALNLF1_C12_09_ABI24.ab1
    1 NNNNNNNNNN NNNNNNNNTG TCTGNTCGNN GCGGCCGGCC GCCCCGACTC TAGAATTATT
   61 ACACGGCGAT CTTGCCGCCC TTCTTGGCCT TAATGAGAAT CTCGCGGATC TTGCGGGCGT
  121 CCAACTTGCC GGTCAGTCCT TTAGGCACCT CGTCCACGAA CACAACACCA CCGCGCAGCT
  181 TCTTGGCGGT TGTAACCTGG CTGGCCACAT AGTCCACGAT CTCCTTCTCG GTCATGGTTT
  241 TACCGTGTTC CAGCACGACG ACTGCGGCGG GCAGCTCGCC GGCATCGTCG TCGGGCAGGC
  301 CGGCGACCCC GGCGTCGAAG ATGTTGGGGT GTTGCAGCAG GATGCTCTCC AGTTCGGCTG
  361 GGGCTACCTG GTAGCCCTTG TATTTGATCA GGCTCTTCAG CCGGTCCACG ATGAAGAAGT
  421 GCTCGTCCTC GTCCCAGTAG GCGATGTCGC CGCTGTGCAG CCAGCCGTCC TTGTCGATGA
  481 GAGCGTTTGT AGCCTCGGGG TTGTTAACGT AGCCGCTCAT GATCATGGGG CCACGGACGC
  541 ACAGCTCGCC GCGCTGGTTC ACACCCAGTG TCTTACCGGT GTCCAAGTCC ACCACCTTAG
  601 CCTCGAAGAA GGGCACCACC TTGCCTACTG CGCCAGGCTT GTCGTCCCCT TCGGGGGTGA
  661 TCAGAATGGC GCTGGTTGTT TCTGTCAGGC CGTAGCCCTG GCGGATGCCT GGTAGGTGGA
  721 AGCGTTTGGC CACGGCCTCA CCTACCTCCT TGCTGAGCGG CGCCCCGCCG CTGGCGATCT
  781 CGTGCAAGTT GCTTANGTCG TACTTGTCGA TGANAGTGCT CTTANCGAAN AANCTAAATA
  841 GTGTGGGCAC CNGCANGGNA GATTGAATCT TATAGTCTTG CAAGCTGCNC AAGAATANCT
  901 NCTCCNCGAA NCGGNACATG ANCNCNANCC GAAAGCCNCA NNTCNNGTAN CCNANNNNNN
  961 NNANNNTGNC NAANCCGNGN NNAAANNNNN NNNCNCNNAN NANAGCGGNN NNNGGGNNNN
1021 ATNNNNNNNN NN
//

Please visit Sequencing and PCR primers for primer information.


References

Original, user report and related articles